SB
| |
SAMSARA BIOCAPITAL, LLC13F | |
| SAMSARA BIOCAPITAL, LLC | |
| Last update 2025-05-15 | 37 Stocks (2 new) |
| Value $561.00 Mil | Turnover 19 % |
SAMSARA BIOCAPITAL, LLC Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SRRK | Scholar Rock Holding Corp | 5,612,896 | 180,454.6 | 0% | 32.180 | 0% | 5.920 | +13.76% | -9.51% | 3,713.3 | Biotechnology | |
KLRS | Kalaris Therapeutics Inc | 11,448,081 | 91,928.1 | New Holding | 16.390 | +16.39% | 61.220 | -56.44% | - | 53.1 | Biotechnology | |
MLYS | Mineralys Therapeutics Inc | 5,674,916 | 90,117.7 | +11.82% | 16.070 | +1.70% | 8.710 | +1.21% | +15.84% | 929.4 | Biotechnology | |
NGNE | Neurogene Inc | 1,717,127 | 20,107.6 | 0% | 3.590 | 0% | 12.040 | +48.41% | -0.22% | 325.3 | Biotechnology | |
ALMS | Alumis Inc | 3,266,498 | 20,056.3 | 0% | 3.580 | 0% | 6.000 | -10.44% | -50.89% | 398.3 | Biotechnology | |
PVLA | Palvella Therapeutics Inc | 679,486 | 19,018.8 | 0% | 3.390 | 0% | 6.150 | +51.67% | +221.92% | 427.1 | Biotechnology | |
SEPN | Septerna Inc | 3,149,128 | 18,233.5 | +13.75% | 3.250 | +0.39% | 7.070 | +109.91% | -40.79% | 604.2 | Biotechnology | |
CRGX | Cargo Therapeutics Inc | 4,415,689 | 17,971.8 | 0% | 3.200 | 0% | 9.580 | -0.11% | -68.65% | 210.3 | Biotechnology | |
LENZ | LENZ Therapeutics Inc | 526,390 | 13,533.5 | -46.67% | 2.410 | -1.82% | 1.870 | +16.74% | +15.69% | 940.1 | Biotechnology | |
UPB | Upstream Bio Inc | 2,067,146 | 12,650.9 | -6.77% | 2.260 | -0.34% | 3.840 | +49.00% | -18.80% | 718.1 | Biotechnology |
SAMSARA BIOCAPITAL, LLC's Historical Top Holdings Breakdowns
SAMSARA BIOCAPITAL, LLC's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
KLRS | Kalaris Therapeutics Inc | 2025-03-31 | New Buy New Buy | +16.39% | 8.03 ($9.78) 11.47 | $2.84 | -70.96% | New holding | 11,448,081 | 11,448,081 | |
LENZ | LENZ Therapeutics Inc | 2025-03-31 | Reduce Reduce | -1.82% | 21.29 ($24.63) 28.46 | $33.40 | 35.61% | Reduce -46.67% | 526,390 | -460,591 | |
JSPR | Jasper Therapeutics Inc | 2025-03-31 | Sold Out Sold Out | -1.72% | 4.3 ($6.65) 21.09 | $3.13 | -52.93% | Sold Out | 0 | -584,642 | |
MLYS | Mineralys Therapeutics Inc | 2025-03-31 | Add Add | +1.70% | 8.76 ($11.5) 16.87 | $14.26 | 24.00% | Add 11.82% | 5,674,916 | 600,000 | |
ACLX | Arcellx Inc | 2025-03-31 | Reduce Reduce | -1.25% | 60.26 ($67.74) 79.13 | $70.27 | 3.73% | Reduce -46.67% | 135,276 | -118,365 | |
ACRS | Aclaris Therapeutics Inc | 2025-03-31 | Sold Out Sold Out | -0.81% | 1.53 ($2.13) 2.6 | $1.68 | -21.13% | Sold Out | 0 | -2,385,060 | |
ZYME | Zymeworks Inc | 2025-03-31 | Reduce Reduce | -0.67% | 11.1 ($13.64) 15.01 | $14.01 | 2.71% | Reduce -33.33% | 666,667 | -333,333 | |
CLYM | Climb Bio Inc | 2025-03-31 | Sold Out Sold Out | -0.64% | 1.22 ($1.62) 2.3 | $1.48 | -8.64% | Sold Out | 0 | -2,609,114 | |
VRNA | Verona Pharma PLC | 2025-03-31 | Sold Out Sold Out | -0.62% | 44.81 ($59.82) 69.63 | $105.00 | 75.53% | Sold Out | 0 | -97,625 | |
SRZN | Surrozen Inc | 2025-03-31 | New Buy New Buy | +0.50% | 9.7 ($11.62) 17.02 | $8.82 | -24.05% | New holding | 241,400 | 241,400 |
SAMSARA BIOCAPITAL, LLC Total Holding History ($B)
SAMSARA BIOCAPITAL, LLC's Asset Allocation
SAMSARA BIOCAPITAL, LLC Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
SAMSARA BIOCAPITAL, LLC's Hypothetical Growth since 2025-03-31
SAMSARA BIOCAPITAL, LLC's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
SAMSARA BIOCAPITAL, LLC's Holdings Heat Map
Size field:
SAMSARA BIOCAPITAL, LLC's Holdings Bubble Chart
SAMSARA BIOCAPITAL, LLC News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers